Elevance Health, Inc. (ELV)
289.64
+3.16
(+1.10%)
USD |
NYSE |
Mar 06, 16:00
288.03
-1.61
(-0.56%)
After-Hours: 20:00
Elevance Health R&D to Revenue (TTM)
R&D to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D to Revenue Definition
The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.
R&D to Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median